-
Innovation Ranking
New![]()
Innovation Ranking – Hypera SA
Hypera SA (Hypera Pharma), formerly Hypermarcas SA, develops, manufactures and markets pharmaceutical and healthcare products. The company operates through prescription products, consumer health, and similar and generic business units. Its product range comprises of sweeteners, anti-flu medications, painkillers, vitamins and supplements, solutions, and tablets for heartburn and poor digestion. Hypera Pharma also offers medicines for dermatology, pediatrics, gastroenterology, women's health, cardiometabolic, musculoskeletal, rheumatology, respiratory, central nervous system, and ophthalmology indications. The company markets its products online and through a network...
-
Company Insights
![]()
Innovation and Patenting activity of Hypera SA Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Hypera SA Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Profile
New![]()
Hypera SA – Company Profile
Hypera SA (Hypera Pharma), formerly Hypermarcas SA, develops, manufactures and markets pharmaceutical and healthcare products. The company operates through prescription products, consumer health, and similar and generic business units. Its product range comprises of sweeteners, anti-flu medications, painkillers, vitamins and supplements, solutions, and tablets for heartburn and poor digestion. Hypera Pharma also offers medicines for dermatology, pediatrics, gastroenterology, women's health, cardiometabolic, musculoskeletal, rheumatology, respiratory, central nervous system, and ophthalmology indications. The company markets its products online and through a network...
Add to Basket -
Thematic Analysis
![]()
Impact of Brazil on the Pharmaceutical Industry – Thematic Intelligence
Brazil Pharmaceutical Market Report Overview Brazil is the largest pharmaceutical market in Central/Southern America and is the 12th largest in the world. Brazil is an untapped market for big pharma manufacturing, with domestic companies dominating the marketed products landscape. The domestic pharmaceutical companies will continue to grow due to favorable policies provided by the Brazilian government to promote domestic production of medicines. Furthermore, over the years, Brazil has elevated its infrastructure, scientific, and technological facilities and has created a sustainable...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.